A general goodness-of-fit test for Markov and hidden Markov models

Statistics in Medicine

Volumn 27, Issue 12, 2008, Pages 2177-2195

  Titman, Andrew C ^a   Sharples, Linda D ^a  

^a MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

Goodness of fit; Hidden Markov model; Markov model

Indexed keywords

ANALYTIC METHOD; ANALYTICAL ERROR; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; DEATH; DISEASE COURSE; HEART TRANSPLANTATION; HIDDEN MARKOV MODEL; HUMAN; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; MAXIMUM LIKELIHOOD METHOD; MONTE CARLO METHOD; PHASE TRANSITION; PROBABILITY; PROGNOSIS; TIME;

ALGORITHMS; DATA INTERPRETATION, STATISTICAL; HEART TRANSPLANTATION; HUMANS; MARKOV CHAINS; MODELS, STATISTICAL; POSTOPERATIVE CARE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 44649181584     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3033     Document Type: Article

References (19)

1. Cox DR, Miller HD. The Theory of Stochastic Processes. Chapman & Hall: London, 1965.
2. Kalbfleisch JD, Lawless JF. The analysis of panel data under a Markov assumption. Journal of the American Statistical Association 1985; 80:863-871.
3. Sharples LD. Use of the Gibbs sampler to estimate transition rates between grades of coronary disease following cardiac transplantation. Statistics in Medicine 1993; 12:1155-1169.
4. Gentleman RC, Lawless JF, Lindsey JC, Yan P. Multi-state Markov models for analysing incomplete disease data with illustrations for HIV disease. Statistics in Medicine 1994; 13:805-821.
5. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. Journal of Rheumatology 1995; 22:675-679.
6. Saint-Pierre P, Combescure C, Daures JP, Godard P. The analysis of asthma control under a Markov assumption with use of covariates. Statistics in Medicine 2003; 22:3755-3770.
7. Jackson CH, Sharples LD, Thompson SG, Duffy SW, Couto E. Multistate Markov models for disease progression with classification error. Journal of the Royal Statistical Society, Series D 2003; 52:193-209.
8. Gruger J, Kay R, Schumacher M. The validity of inferences based on incomplete observations in disease state models. Biometrics 1991; 47:595-605.
9. Kay R. A Markov model for analysing cancer markers and diseases states in survival studies. Biometrics 1986; 42:855-865.
10. Stavola de BL. Testing departures from time homogeneity in multistate Markov processes. Applied Statistics 1988; 37:242-250.
11. Aguirre-Hernandez R, Farewell VT. A Pearson-type goodness-of-fit test for stationary and time-continuous Markov regression models. Statistics in Medicine 2002; 21:1899-1911.
12. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Chapman & Hall: New York, 1993.
13. Sharples LD, Jackson CH, Parameshwar J, Wallwork J, Large SR. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy. Transplantation 2003; 76:679-682.
14. Satten GA, Longini IM. Markov chains with measurement error: estimating the 'true' course of a marker of the progression of human immunodeficiency virus disease. Journal of the Royal Statistical Society, Series C 1996; 45:265-309.
15. Jackson CH, Sharples LD. Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients. Statistics in Medicine 2002; 21:113-128.
16. Bureau A, Shiboski S, Hughes JP. Applications of continuous time hidden Markov models to the study of misclassified disease outcomes. Statistics in Medicine 2003; 22:441-462.
17. Satten GA. Estimating the extent of tracking in interval-censored chain-of-events data. Biometrics 1999; 55: 1228-1231.
18. Cook RJ, Yi GY, Lee K. A conditional Markov model for clustered progressive multistate processes under incomplete observation. Biometrics 2004; 60:436-443.
19. Agresti A. Categorical Data Analysis (2nd edn), Wiley: New York, 2002.